Acctena | Repositioning Clinical Stage Drugs

site profile thumbnail


Acctena is a Swedish company that aims to reposition “abandoned” drugs to become beneficial medicines for new diseases. Their strategy is to bring selected drugs directly into phase 2 studies for new clinical use and expanded intellectual property.

More by Charbel Hajj

See profile